Enochian Biosciences, Inc.
Index- P/E- EPS (ttm)-2.04 Insider Own61.70% Shs Outstand55.51M Perf Week-6.62%
Market Cap50.24M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float20.28M Perf Month-12.85%
Income-108.60M PEG- EPS next Q- Inst Own7.20% Short Float / Ratio8.14% / 30.72 Perf Quarter-12.85%
Sales- P/S- EPS this Y-281.10% Inst Trans-4.03% Short Interest1.65M Perf Half Y-52.59%
Book/sh1.21 P/B0.76 EPS next Y- ROA-101.50% Target Price- Perf Year-88.65%
Cash/sh0.07 P/C12.25 EPS next 5Y- ROE-117.10% 52W Range0.90 - 8.88 Perf YTD-11.16%
Dividend- P/FCF- EPS past 5Y-65.40% ROI- 52W High-89.69% Beta1.11
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin- 52W Low1.68% ATR0.10
Employees11 Current Ratio0.50 Sales Q/Q- Oper. Margin- RSI (14)39.44 Volatility10.71% 9.69%
OptionableYes Debt/Eq0.09 EPS Q/Q36.20% Profit Margin- Rel Volume1.39 Prev Close0.93
ShortableYes LT Debt/Eq0.02 Earnings- Payout- Avg Volume53.76K Price0.92
Recom- SMA20-12.84% SMA50-14.93% SMA200-48.42% Volume74,918 Change-1.60%
Mar-29-23 09:00AM
Mar-13-23 08:30AM
Feb-23-23 04:04PM
Nov-30-22 05:20PM
Oct-26-22 12:01AM
08:11PM Loading…
Oct-24-22 08:11PM
Oct-21-22 05:00PM
Oct-17-22 08:30AM
Sep-01-22 08:08AM
Jul-25-22 10:15AM
Jul-01-22 08:37PM
Jun-27-22 03:00PM
Jun-10-22 04:00PM
05:59PM Loading…
Jun-09-22 05:59PM
May-31-22 08:00AM
May-25-22 04:20PM
Apr-20-22 07:00AM
Apr-07-22 06:00AM
Apr-06-22 09:07AM
Apr-05-22 06:00AM
Mar-25-22 12:07PM
Mar-15-22 07:00AM
Dec-03-21 07:00AM
Oct-18-21 07:00AM
Oct-15-21 06:00PM
Oct-12-21 06:00PM
Sep-27-21 07:00AM
Sep-26-21 10:42AM
07:00AM Loading…
Sep-13-21 07:00AM
Aug-30-21 07:00AM
Aug-23-21 10:18AM
Jul-20-21 07:00AM
Jul-12-21 08:37AM
Jun-30-21 07:00AM
Jun-21-21 05:31PM
Jun-15-21 09:05AM
Jun-14-21 03:15PM
May-12-21 04:29PM
Apr-30-21 03:42AM
Mar-24-21 06:00PM
Feb-22-21 05:15PM
Nov-01-20 09:35AM
Sep-10-20 12:50AM
Jul-27-20 08:00AM
Jun-08-20 07:30AM
May-14-20 09:50AM
May-13-20 08:00AM
Apr-23-20 07:00AM
Apr-09-20 10:00AM
Feb-24-20 07:30AM
Feb-03-20 07:30AM
Jan-06-20 07:30AM
Dec-10-19 07:00AM
Nov-25-19 07:00AM
Nov-21-19 10:30AM
Oct-31-19 04:17PM
Oct-26-19 10:18AM
Jun-03-19 07:00AM
Apr-29-19 09:19AM
Mar-07-19 12:45PM
Feb-01-19 02:31PM
Jan-16-19 04:00PM
Jan-07-19 08:30AM
Jan-04-19 08:00AM
Dec-05-18 08:30AM
Dec-03-18 08:30AM
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sindlev ReneDirectorMay 18Buy8.00253,4932,027,944128,493May 20 09:32 PM
Gumrukcu Serhat10% OwnerMay 18Sale8.00253,4932,027,94412,273,059May 20 09:37 PM